These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. Acred P, Ryan DM, Sowa MA, Watts CM. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994 [Abstract] [Full Text] [Related]
12. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Jones RN, Erwin ME, Barrett MS, Johnson DM, Briggs BM. Diagn Microbiol Infect Dis; 1991 Sep; 14(4):301-9. PubMed ID: 1889181 [Abstract] [Full Text] [Related]
13. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin. Bremner DA. Chemotherapy; 1983 Sep; 29(4):283-8. PubMed ID: 6307605 [Abstract] [Full Text] [Related]
14. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin. Neu HC. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175 [Abstract] [Full Text] [Related]
19. The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria. Zhang YL, Li JT. Int J Antimicrob Agents; 2001 Feb; 17(2):143-6. PubMed ID: 11165119 [Abstract] [Full Text] [Related]